img

Global Dementia Treatment Market Research Report 2024


Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical

Publisher : MRA | Format : PDF

Global Dementia Treatment Market Research Report 2024

Donepezil (also known as Aricept), rivastigmine (Exelon) and galantamine (Reminyl) are used to treat the symptoms of mild to moderate Alzheimer's disease.
According to MRAResearch’s new survey, global Dementia Treatment market is projected to reach US$ 4384.5 million in 2033, increasing from US$ 3640 million in 2022, with the CAGR of 2.8% during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Dementia Treatment market research.
The Dementia Treatment market is driven by the aging global population and the subsequent increase in the prevalence of dementia-related disorders, such as Alzheimer's disease. As healthcare systems strive to address the growing burden of cognitive decline, research into effective treatments and interventions has intensified. Advancements in neuroscience and understanding of the underlying causes of dementia have led to the development of novel therapeutic approaches, including disease-modifying drugs and targeted interventions. However, challenges persist, such as the complexity of dementia etiology, the lack of a definitive cure, and the need for early and accurate diagnosis. Additionally, there is a need to enhance awareness, reduce stigma, and improve access to care and support services for both patients and caregivers. The Dementia Treatment market's potential can be harnessed by investing in research, promoting interdisciplinary collaborations, and tailoring treatment strategies to meet the diverse needs of patients across different stages of the disease.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Dementia Treatment market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.



By Company


Allergan
Eisai
Novartis
Daiichi Sankyo
Merz Pharma
Pfizer
Johnson & Johnson
Lundbeck
Segment by Type
Donepezil
Memantine
Rivastigmine
Others

Segment by Application


Hospitals
Drugstores
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Dementia Treatment report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Dementia Treatment Market Size Growth Rate by Type: 2018 VS 2022 VS 2033
1.2.2 Donepezil
1.2.3 Memantine
1.2.4 Rivastigmine
1.2.5 Others
1.3 Market by Application
1.3.1 Global Dementia Treatment Market Growth by Application: 2018 VS 2022 VS 2033
1.3.2 Hospitals
1.3.3 Drugstores
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Dementia Treatment Market Perspective (2018-2033)
2.2 Dementia Treatment Growth Trends by Region
2.2.1 Global Dementia Treatment Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Dementia Treatment Historic Market Size by Region (2018-2023)
2.2.3 Dementia Treatment Forecasted Market Size by Region (2024-2033)
2.3 Dementia Treatment Market Dynamics
2.3.1 Dementia Treatment Industry Trends
2.3.2 Dementia Treatment Market Drivers
2.3.3 Dementia Treatment Market Challenges
2.3.4 Dementia Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Dementia Treatment Players by Revenue
3.1.1 Global Top Dementia Treatment Players by Revenue (2018-2023)
3.1.2 Global Dementia Treatment Revenue Market Share by Players (2018-2023)
3.2 Global Dementia Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Dementia Treatment Revenue
3.4 Global Dementia Treatment Market Concentration Ratio
3.4.1 Global Dementia Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Dementia Treatment Revenue in 2022
3.5 Dementia Treatment Key Players Head office and Area Served
3.6 Key Players Dementia Treatment Product Solution and Service
3.7 Date of Enter into Dementia Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Dementia Treatment Breakdown Data by Type
4.1 Global Dementia Treatment Historic Market Size by Type (2018-2023)
4.2 Global Dementia Treatment Forecasted Market Size by Type (2024-2033)
5 Dementia Treatment Breakdown Data by Application
5.1 Global Dementia Treatment Historic Market Size by Application (2018-2023)
5.2 Global Dementia Treatment Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Dementia Treatment Market Size (2018-2033)
6.2 North America Dementia Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2033
6.3 North America Dementia Treatment Market Size by Country (2018-2023)
6.4 North America Dementia Treatment Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Dementia Treatment Market Size (2018-2033)
7.2 Europe Dementia Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2033
7.3 Europe Dementia Treatment Market Size by Country (2018-2023)
7.4 Europe Dementia Treatment Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Dementia Treatment Market Size (2018-2033)
8.2 Asia-Pacific Dementia Treatment Market Growth Rate by Region: 2018 VS 2022 VS 2033
8.3 Asia-Pacific Dementia Treatment Market Size by Region (2018-2023)
8.4 Asia-Pacific Dementia Treatment Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Dementia Treatment Market Size (2018-2033)
9.2 Latin America Dementia Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2033
9.3 Latin America Dementia Treatment Market Size by Country (2018-2023)
9.4 Latin America Dementia Treatment Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Dementia Treatment Market Size (2018-2033)
10.2 Middle East & Africa Dementia Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2033
10.3 Middle East & Africa Dementia Treatment Market Size by Country (2018-2023)
10.4 Middle East & Africa Dementia Treatment Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Allergan
11.1.1 Allergan Company Detail
11.1.2 Allergan Business Overview
11.1.3 Allergan Dementia Treatment Introduction
11.1.4 Allergan Revenue in Dementia Treatment Business (2018-2023)
11.1.5 Allergan Recent Development
11.2 Eisai
11.2.1 Eisai Company Detail
11.2.2 Eisai Business Overview
11.2.3 Eisai Dementia Treatment Introduction
11.2.4 Eisai Revenue in Dementia Treatment Business (2018-2023)
11.2.5 Eisai Recent Development
11.3 Novartis
11.3.1 Novartis Company Detail
11.3.2 Novartis Business Overview
11.3.3 Novartis Dementia Treatment Introduction
11.3.4 Novartis Revenue in Dementia Treatment Business (2018-2023)
11.3.5 Novartis Recent Development
11.4 Daiichi Sankyo
11.4.1 Daiichi Sankyo Company Detail
11.4.2 Daiichi Sankyo Business Overview
11.4.3 Daiichi Sankyo Dementia Treatment Introduction
11.4.4 Daiichi Sankyo Revenue in Dementia Treatment Business (2018-2023)
11.4.5 Daiichi Sankyo Recent Development
11.5 Merz Pharma
11.5.1 Merz Pharma Company Detail
11.5.2 Merz Pharma Business Overview
11.5.3 Merz Pharma Dementia Treatment Introduction
11.5.4 Merz Pharma Revenue in Dementia Treatment Business (2018-2023)
11.5.5 Merz Pharma Recent Development
11.6 Pfizer
11.6.1 Pfizer Company Detail
11.6.2 Pfizer Business Overview
11.6.3 Pfizer Dementia Treatment Introduction
11.6.4 Pfizer Revenue in Dementia Treatment Business (2018-2023)
11.6.5 Pfizer Recent Development
11.7 Johnson & Johnson
11.7.1 Johnson & Johnson Company Detail
11.7.2 Johnson & Johnson Business Overview
11.7.3 Johnson & Johnson Dementia Treatment Introduction
11.7.4 Johnson & Johnson Revenue in Dementia Treatment Business (2018-2023)
11.7.5 Johnson & Johnson Recent Development
11.8 Lundbeck
11.8.1 Lundbeck Company Detail
11.8.2 Lundbeck Business Overview
11.8.3 Lundbeck Dementia Treatment Introduction
11.8.4 Lundbeck Revenue in Dementia Treatment Business (2018-2023)
11.8.5 Lundbeck Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Dementia Treatment Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2033
Table 2. Key Players of Donepezil
Table 3. Key Players of Memantine
Table 4. Key Players of Rivastigmine
Table 5. Key Players of Others
Table 6. Global Dementia Treatment Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2033
Table 7. Global Dementia Treatment Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 8. Global Dementia Treatment Market Size by Region (2018-2023) & (US$ Million)
Table 9. Global Dementia Treatment Market Share by Region (2018-2023)
Table 10. Global Dementia Treatment Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 11. Global Dementia Treatment Market Share by Region (2024-2033)
Table 12. Dementia Treatment Market Trends
Table 13. Dementia Treatment Market Drivers
Table 14. Dementia Treatment Market Challenges
Table 15. Dementia Treatment Market Restraints
Table 16. Global Dementia Treatment Revenue by Players (2018-2023) & (US$ Million)
Table 17. Global Dementia Treatment Market Share by Players (2018-2023)
Table 18. Global Top Dementia Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Dementia Treatment as of 2022)
Table 19. Ranking of Global Top Dementia Treatment Companies by Revenue (US$ Million) in 2022
Table 20. Global 5 Largest Players Market Share by Dementia Treatment Revenue (CR5 and HHI) & (2018-2023)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Dementia Treatment Product Solution and Service
Table 23. Date of Enter into Dementia Treatment Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Dementia Treatment Market Size by Type (2018-2023) & (US$ Million)
Table 26. Global Dementia Treatment Revenue Market Share by Type (2018-2023)
Table 27. Global Dementia Treatment Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 28. Global Dementia Treatment Revenue Market Share by Type (2024-2033)
Table 29. Global Dementia Treatment Market Size by Application (2018-2023) & (US$ Million)
Table 30. Global Dementia Treatment Revenue Market Share by Application (2018-2023)
Table 31. Global Dementia Treatment Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 32. Global Dementia Treatment Revenue Market Share by Application (2024-2033)
Table 33. North America Dementia Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 34. North America Dementia Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 35. North America Dementia Treatment Market Size by Country (2024-2033) & (US$ Million)
Table 36. Europe Dementia Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 37. Europe Dementia Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 38. Europe Dementia Treatment Market Size by Country (2024-2033) & (US$ Million)
Table 39. Asia-Pacific Dementia Treatment Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2033
Table 40. Asia-Pacific Dementia Treatment Market Size by Region (2018-2023) & (US$ Million)
Table 41. Asia-Pacific Dementia Treatment Market Size by Region (2024-2033) & (US$ Million)
Table 42. Latin America Dementia Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 43. Latin America Dementia Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 44. Latin America Dementia Treatment Market Size by Country (2024-2033) & (US$ Million)
Table 45. Middle East & Africa Dementia Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 46. Middle East & Africa Dementia Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 47. Middle East & Africa Dementia Treatment Market Size by Country (2024-2033) & (US$ Million)
Table 48. Allergan Company Detail
Table 49. Allergan Business Overview
Table 50. Allergan Dementia Treatment Product
Table 51. Allergan Revenue in Dementia Treatment Business (2018-2023) & (US$ Million)
Table 52. Allergan Recent Development
Table 53. Eisai Company Detail
Table 54. Eisai Business Overview
Table 55. Eisai Dementia Treatment Product
Table 56. Eisai Revenue in Dementia Treatment Business (2018-2023) & (US$ Million)
Table 57. Eisai Recent Development
Table 58. Novartis Company Detail
Table 59. Novartis Business Overview
Table 60. Novartis Dementia Treatment Product
Table 61. Novartis Revenue in Dementia Treatment Business (2018-2023) & (US$ Million)
Table 62. Novartis Recent Development
Table 63. Daiichi Sankyo Company Detail
Table 64. Daiichi Sankyo Business Overview
Table 65. Daiichi Sankyo Dementia Treatment Product
Table 66. Daiichi Sankyo Revenue in Dementia Treatment Business (2018-2023) & (US$ Million)
Table 67. Daiichi Sankyo Recent Development
Table 68. Merz Pharma Company Detail
Table 69. Merz Pharma Business Overview
Table 70. Merz Pharma Dementia Treatment Product
Table 71. Merz Pharma Revenue in Dementia Treatment Business (2018-2023) & (US$ Million)
Table 72. Merz Pharma Recent Development
Table 73. Pfizer Company Detail
Table 74. Pfizer Business Overview
Table 75. Pfizer Dementia Treatment Product
Table 76. Pfizer Revenue in Dementia Treatment Business (2018-2023) & (US$ Million)
Table 77. Pfizer Recent Development
Table 78. Johnson & Johnson Company Detail
Table 79. Johnson & Johnson Business Overview
Table 80. Johnson & Johnson Dementia Treatment Product
Table 81. Johnson & Johnson Revenue in Dementia Treatment Business (2018-2023) & (US$ Million)
Table 82. Johnson & Johnson Recent Development
Table 83. Lundbeck Company Detail
Table 84. Lundbeck Business Overview
Table 85. Lundbeck Dementia Treatment Product
Table 86. Lundbeck Revenue in Dementia Treatment Business (2018-2023) & (US$ Million)
Table 87. Lundbeck Recent Development
Table 88. Research Programs/Design for This Report
Table 89. Key Data Information from Secondary Sources
Table 90. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Dementia Treatment Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global Dementia Treatment Market Share by Type: 2022 VS 2033
Figure 3. Donepezil Features
Figure 4. Memantine Features
Figure 5. Rivastigmine Features
Figure 6. Others Features
Figure 7. Global Dementia Treatment Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 8. Global Dementia Treatment Market Share by Application: 2022 VS 2033
Figure 9. Hospitals Case Studies
Figure 10. Drugstores Case Studies
Figure 11. Others Case Studies
Figure 12. Dementia Treatment Report Years Considered
Figure 13. Global Dementia Treatment Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 14. Global Dementia Treatment Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 15. Global Dementia Treatment Market Share by Region: 2022 VS 2033
Figure 16. Global Dementia Treatment Market Share by Players in 2022
Figure 17. Global Top Dementia Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Dementia Treatment as of 2022)
Figure 18. The Top 10 and 5 Players Market Share by Dementia Treatment Revenue in 2022
Figure 19. North America Dementia Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 20. North America Dementia Treatment Market Share by Country (2018-2033)
Figure 21. United States Dementia Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 22. Canada Dementia Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 23. Europe Dementia Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 24. Europe Dementia Treatment Market Share by Country (2018-2033)
Figure 25. Germany Dementia Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 26. France Dementia Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. U.K. Dementia Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. Italy Dementia Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. Russia Dementia Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. Nordic Countries Dementia Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. Asia-Pacific Dementia Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. Asia-Pacific Dementia Treatment Market Share by Region (2018-2033)
Figure 33. China Dementia Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. Japan Dementia Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. South Korea Dementia Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. Southeast Asia Dementia Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. India Dementia Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 38. Australia Dementia Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 39. Latin America Dementia Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 40. Latin America Dementia Treatment Market Share by Country (2018-2033)
Figure 41. Mexico Dementia Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 42. Brazil Dementia Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 43. Middle East & Africa Dementia Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. Middle East & Africa Dementia Treatment Market Share by Country (2018-2033)
Figure 45. Turkey Dementia Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 46. Saudi Arabia Dementia Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 47. Allergan Revenue Growth Rate in Dementia Treatment Business (2018-2023)
Figure 48. Eisai Revenue Growth Rate in Dementia Treatment Business (2018-2023)
Figure 49. Novartis Revenue Growth Rate in Dementia Treatment Business (2018-2023)
Figure 50. Daiichi Sankyo Revenue Growth Rate in Dementia Treatment Business (2018-2023)
Figure 51. Merz Pharma Revenue Growth Rate in Dementia Treatment Business (2018-2023)
Figure 52. Pfizer Revenue Growth Rate in Dementia Treatment Business (2018-2023)
Figure 53. Johnson & Johnson Revenue Growth Rate in Dementia Treatment Business (2018-2023)
Figure 54. Lundbeck Revenue Growth Rate in Dementia Treatment Business (2018-2023)
Figure 55. Bottom-up and Top-down Approaches for This Report
Figure 56. Data Triangulation
Figure 57. Key Executives Interviewed